Droxidopa
30 NDCs across 10 manufacturers|30 Generic,0 Brand
Droxidopa is used to treat orthostatic hypotension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 18, 2014, and the first generic was approved Feb 18, 2021. FDA's Orange Book lists 36 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $69 million on Droxidopa across 40,000 claims for 7,213 beneficiaries.
Droxidopa is available as 30 NDCs from 10 manufacturers (30 generic, 0 brand), with NADAC prices from $0.47 to $2.60 per EA — the most expensive product costs about 5.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
30
30G / 0B
Manufacturers
10
competing in market
Price Spread
$0.47 – $2.60
per EA
7d Activity
avg -2.0% WoW · of 30 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sun Pharmaceutical Industries Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing DROXIDOPA
Frequently Asked Questions
What is Droxidopa used to treat?
Droxidopa is used to treat orthostatic hypotension, per the National Library of Medicine's MED-RT classification.
When did Droxidopa become available as a generic?
FDA approved the first generic Droxidopa (ANDA) on Feb 18, 2021. The Orange Book currently lists 36 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Droxidopa?
In 2024, Medicare Part D spent $69 million on Droxidopa across 40,000 claims for 7,213 beneficiaries.
How many Droxidopa products are on the market?
The Droxidopa drug market contains 30 NDCs from 10 manufacturers — 30 generic and 0 brand products.
What is the price range for Droxidopa?
NADAC reference prices for Droxidopa range from $0.4724 to $2.6037 per EA — the most expensive product costs about 5.5× the cheapest.
Which manufacturers make Droxidopa?
10 manufacturers list Droxidopa in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (3), Slate Run Pharmaceuticals LLC (3), Aurobindo Pharma Limited (3), Ascend Laboratories, LLC (3), ScieGen Pharmaceuticals Inc. (3).
How has the price of Droxidopa changed recently?
Over the past 7 days, 14 Droxidopa NDCs rose and 7 fell, with a market-wide average change of -2.0%.